Skip to main content
. 2020 Feb 27;38(3):455–460. doi: 10.5114/ada.2020.93368

Table 3.

Genotype and allele frequencies for CTLA-4 rs5742909 in BCC patients and controls

Genotypes and alleles BCC group Control group P-value
Recessive model: 0.33
 TT 6 (2.1%) 2 (1.0%)
 CT + CC 274 (97.9%) 198 (99.0%)
Dominant model: 0.78
 TT + CT 56 (20.0%) 38 (19.0%)
 CC 224 (80.0%) 162 (81.0%)
Overdominant model: 0.97
 CT 50 (17.9%) 36 (18.0%)
 CC + TT 230 (82.1% 164 (82.0%)
C 498 (88.9%) 360 (90.0%) 0.59
T 62 (11.1%) 40 (10.0%)